Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 9 | 2026 | 732 | 2.530 |
Why?
|
| Robotic Surgical Procedures | 6 | 2026 | 207 | 2.250 |
Why?
|
| Cholestasis | 2 | 2023 | 217 | 1.160 |
Why?
|
| Renal Nutcracker Syndrome | 2 | 2025 | 8 | 1.070 |
Why?
|
| Liver Transplantation | 6 | 2023 | 841 | 0.930 |
Why?
|
| Flank Pain | 1 | 2024 | 9 | 0.860 |
Why?
|
| Transplantation, Autologous | 2 | 2025 | 307 | 0.830 |
Why?
|
| Kidney Failure, Chronic | 2 | 2026 | 600 | 0.710 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2021 | 28 | 0.650 |
Why?
|
| Renal Veins | 2 | 2025 | 18 | 0.440 |
Why?
|
| Vesicovaginal Fistula | 1 | 2013 | 5 | 0.390 |
Why?
|
| Operative Time | 3 | 2026 | 195 | 0.370 |
Why?
|
| Length of Stay | 3 | 2026 | 1371 | 0.370 |
Why?
|
| Wilms Tumor | 1 | 2013 | 90 | 0.360 |
Why?
|
| Tumor Burden | 1 | 2013 | 327 | 0.360 |
Why?
|
| Retrospective Studies | 10 | 2026 | 17560 | 0.350 |
Why?
|
| Treatment Outcome | 7 | 2026 | 11947 | 0.350 |
Why?
|
| Surgical Flaps | 1 | 2013 | 142 | 0.350 |
Why?
|
| Delayed Graft Function | 3 | 2026 | 54 | 0.350 |
Why?
|
| Catheterization | 2 | 2023 | 184 | 0.330 |
Why?
|
| Constriction, Pathologic | 2 | 2023 | 252 | 0.330 |
Why?
|
| Vagina | 1 | 2013 | 206 | 0.330 |
Why?
|
| Thrombelastography | 3 | 2020 | 192 | 0.300 |
Why?
|
| Autonomic Dysreflexia | 1 | 2007 | 4 | 0.260 |
Why?
|
| Penis | 1 | 2007 | 36 | 0.260 |
Why?
|
| Postoperative Complications | 3 | 2026 | 3022 | 0.260 |
Why?
|
| Physical Stimulation | 1 | 2007 | 69 | 0.260 |
Why?
|
| Body Mass Index | 2 | 2026 | 2470 | 0.250 |
Why?
|
| Vibration | 1 | 2007 | 71 | 0.250 |
Why?
|
| Middle Aged | 12 | 2026 | 36821 | 0.240 |
Why?
|
| Neostigmine | 1 | 2026 | 21 | 0.230 |
Why?
|
| Hypoventilation | 1 | 2026 | 17 | 0.230 |
Why?
|
| Brain Death | 1 | 2026 | 60 | 0.230 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2026 | 82 | 0.230 |
Why?
|
| Neuromuscular Blockade | 1 | 2026 | 54 | 0.220 |
Why?
|
| Nephrectomy | 1 | 2026 | 172 | 0.220 |
Why?
|
| Adult | 11 | 2026 | 41405 | 0.220 |
Why?
|
| Spinal Cord Injuries | 1 | 2007 | 240 | 0.200 |
Why?
|
| Salvage Therapy | 1 | 2024 | 166 | 0.190 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2026 | 244 | 0.190 |
Why?
|
| Tissue Donors | 1 | 2026 | 427 | 0.190 |
Why?
|
| Humans | 21 | 2026 | 147293 | 0.190 |
Why?
|
| Primary Graft Dysfunction | 1 | 2023 | 33 | 0.180 |
Why?
|
| Male | 13 | 2026 | 73950 | 0.180 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2023 | 248 | 0.180 |
Why?
|
| Tissue and Organ Procurement | 1 | 2026 | 350 | 0.180 |
Why?
|
| Pain Measurement | 1 | 2024 | 569 | 0.170 |
Why?
|
| Female | 13 | 2026 | 80076 | 0.170 |
Why?
|
| Time Factors | 4 | 2024 | 7173 | 0.170 |
Why?
|
| Stents | 1 | 2025 | 570 | 0.160 |
Why?
|
| Decision Support Techniques | 1 | 2025 | 480 | 0.160 |
Why?
|
| Reperfusion | 1 | 2020 | 54 | 0.160 |
Why?
|
| Hemostatic Techniques | 1 | 2020 | 52 | 0.150 |
Why?
|
| Blood Component Transfusion | 1 | 2020 | 104 | 0.150 |
Why?
|
| Blood Coagulation | 1 | 2020 | 274 | 0.140 |
Why?
|
| Graft Survival | 3 | 2026 | 534 | 0.140 |
Why?
|
| Blood Coagulation Disorders | 1 | 2020 | 198 | 0.140 |
Why?
|
| Resuscitation | 1 | 2020 | 318 | 0.130 |
Why?
|
| United States | 2 | 2026 | 16313 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 1167 | 0.110 |
Why?
|
| Oxalic Acid | 1 | 2014 | 4 | 0.100 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2014 | 23 | 0.100 |
Why?
|
| Blood Transfusion | 1 | 2017 | 412 | 0.100 |
Why?
|
| Kidney | 2 | 2026 | 1511 | 0.090 |
Why?
|
| Obesity | 1 | 2026 | 3149 | 0.090 |
Why?
|
| Blood Loss, Surgical | 1 | 2013 | 116 | 0.090 |
Why?
|
| Hysterectomy | 1 | 2013 | 138 | 0.090 |
Why?
|
| Patient Care Management | 1 | 2011 | 56 | 0.080 |
Why?
|
| Aged | 3 | 2026 | 26514 | 0.080 |
Why?
|
| Recurrence | 1 | 2013 | 1151 | 0.080 |
Why?
|
| Continuity of Patient Care | 1 | 2011 | 300 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2014 | 1141 | 0.060 |
Why?
|
| Young Adult | 1 | 2024 | 14437 | 0.060 |
Why?
|
| Warm Ischemia | 1 | 2026 | 28 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2011 | 1018 | 0.060 |
Why?
|
| Anesthesia Recovery Period | 1 | 2026 | 28 | 0.060 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2026 | 34 | 0.060 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2026 | 47 | 0.060 |
Why?
|
| Software | 1 | 2011 | 683 | 0.060 |
Why?
|
| Markov Chains | 1 | 2025 | 132 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 2133 | 0.050 |
Why?
|
| Adolescent | 1 | 2024 | 22825 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2020 | 8164 | 0.050 |
Why?
|
| Choledochostomy | 1 | 2022 | 10 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 2791 | 0.050 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2022 | 26 | 0.050 |
Why?
|
| Bile Ducts | 1 | 2022 | 68 | 0.050 |
Why?
|
| Allografts | 1 | 2023 | 152 | 0.040 |
Why?
|
| Death | 1 | 2023 | 132 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2026 | 2080 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2020 | 69 | 0.040 |
Why?
|
| Computer Systems | 1 | 2020 | 55 | 0.040 |
Why?
|
| Viscosity | 1 | 2020 | 92 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2020 | 105 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2011 | 1279 | 0.040 |
Why?
|
| Living Donors | 1 | 2022 | 289 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2014 | 5272 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 2020 | 156 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2020 | 351 | 0.040 |
Why?
|
| Infant | 1 | 2013 | 10194 | 0.040 |
Why?
|
| Incidence | 1 | 2026 | 2954 | 0.040 |
Why?
|
| Fibrinolysis | 1 | 2020 | 164 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2013 | 12016 | 0.030 |
Why?
|
| Janus Kinase 1 | 1 | 2014 | 26 | 0.030 |
Why?
|
| Nephritis | 1 | 2014 | 22 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2014 | 50 | 0.030 |
Why?
|
| Child | 1 | 2013 | 22979 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 337 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 264 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2014 | 762 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 1186 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 318 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 507 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 848 | 0.020 |
Why?
|
| Efficiency | 1 | 2011 | 103 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 1721 | 0.020 |
Why?
|
| Workload | 1 | 2011 | 172 | 0.020 |
Why?
|
| Safety | 1 | 2011 | 358 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2832 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 11017 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 3784 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 984 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1794 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2812 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2011 | 712 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 3448 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 6164 | 0.010 |
Why?
|